Celanese Corporation [CE] Stock Forecast

Q: What is Celanese Corporation stock symbol ?

Celanese Corporation is a US stock, located in Irving of Tx and trading under the symbol CE

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?

CE Stock Summary

Earnings have grown 13.31% per last year.

Earnings are expected to rise 1.61% next year

EPS has been increasing for the past 3 years (Yearly statements)

CE's dividend payments are well covered by cash flows with cash payout ratio of 24.02%.

Has a high level of debt. Debt-to-Equity ratio of 2.62 is considered high.

Profit margins (0.12%) are lower than the previous year (0.2%)

CE has less than 1 year of cash runway

Top 10 Correlated ETFs

CE

Top 10 Correlated Stocks

CE

In the News

02:46 27 Sep 2023 CE

The 7 Most Undervalued Warren Buffett Stocks to Buy in September 2023

If you're among the millions of investors concerned about where to put your money to work, undervalued Warren Buffett stocks to buy may be the place to focus on. Specifically, by aligning your portfolio with certain compelling individual holdings of Berkshire Hathaway (NYSE: BRK-B ), you might be able to get a leg up on market vagaries.

01:41 27 Sep 2023 CE

The 3 Most Undervalued Materials Stocks to Buy in September 2023

My mission, should I choose to accept it, is to find the three most undervalued materials stocks to buy in September. Dr. Ed Yardeni and his capable crew at Yardeni Research produce interesting charts weekly about the S&P 500.

07:31 27 Sep 2023 CE

Celanese (CE) Inks Deal With Population Council for VitalDose

The VitalDose platform by Celanese (CE) Delivery Platform has a long history of application in approved parenteral drug options.

12:47 27 Sep 2023 CE

Celanese (CE) Up 0.8% Since Last Earnings Report: Can It Continue?

Celanese (CE) reported earnings 30 days ago. What's next for the stock?

03:35 27 Sep 2023 CE

Warren Buffett Just Sold These 3 Stocks. You Should Too.

Warren Buffet is arguably the most successful investor of all time. And while he is known as both a value investor and a long-term, buy-and-hold market participant, he's not averse to selling a stock if it runs against him or the reasons why he bought shares in the first place turn out to be incorrect.

11:00 27 Sep 2023 CE

Celanese (CE) Refinances Debt to Extend Maturity & Reduce Costs

Celanese (CE) is refinancing its debt to extend the maturity of its debt and reduce its borrowing costs by 14 basis points.

05:09 27 Sep 2023 CE

Warren Buffett's Berkshire Hathaway bet on 3 homebuilders - and sold and slashed a bunch of stocks last quarter

Warren Buffett's Berkshire Hathaway added a trio of homebuilders to its portfolio last quarter. The investor's company exited three stocks and slashed several of its positions, SEC filings show.

01:40 27 Sep 2023 CE

Celanese (CE) Q2 Earnings and Sales Fall Short of Estimates

Celanese (CE) misses second-quarter earnings and sales estimates due to slow demand recovery and production cuts.

07:39 27 Sep 2023 CE

Celanese (CE) Reports Q2 Earnings: What Key Metrics Have to Say

The headline numbers for Celanese (CE) give insight into how the company performed in the quarter ended June 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

06:54 27 Sep 2023 CE

Celanese (CE) Q2 Earnings and Revenues Miss Estimates

Celanese (CE) came out with quarterly earnings of $2.17 per share, missing the Zacks Consensus Estimate of $2.46 per share. This compares to earnings of $4.99 per share a year ago.

CE Financial details

Company Rating

Strong Buy

Market Cap

13.49B

Income

1.27B

Revenue

10.3B

Book val./share

51.64

Cash/share

11.9

Dividend

2.8

Dividend %

2.33%

Employees

13.26K

Optionable

Shortable

Yes

Earnings

01 Nov 2023

P/E

10.31

Forward P/E

PEG

-3.31

P/S

1.27

P/B

2.33

P/C

10.25

P/FCF

12.07

Quick Ratio

0.83

Current Ratio

1.59

Debt / Equity

2.62

LT Debt / Equity

2.35

EPS (TTM)

11.69

EPS next Y

EPS next Q

5.66

EPS this Y

2.88%

EPS next Y

EPS next 5Y

74.38%

EPS last 5Y

14.22%

Revenue last 5Y

6.22%

Revenue Q/Q

-2.03%

EPS Q/Q

140.48%

SMA20

3.31%

SMA50

3.31%

SMA100

21.36%

Inst Own

99.38%

Inst Trans

1.05%

ROA

ROE

23%

ROC

0.05%

Gross Margin

22%

Oper. Margin

11%

Profit Margin

12%

Payout

24%

Shs Outstand

108.85M

Shs Float

103.05M

Target Price

153.69

52W Range

86.71-131.05

52W High

-6.86%

52W Low

+41.87%

RSI

Rel Volume

0.2

Avg Volume

1.26M

Volume

253.6K

Perf Week

-4.9%

Perf Month

4.82%

Perf Quarter

15.07%

Perf Half Y

18.16%

Beta

1.30947

Volatility

2.64%, 3.94%

Prev Close

1.57%

Price

122.01

Change

-0.25%

CE Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2022-12-31

Metric	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31
Revenue per share	53.28	50.82	48.01	76.76	89.25
Net income per share	8.99	6.88	16.85	16.99	17.48
Operating cash flow per share	11.6	11.74	7.22	15.8	16.78
Free cash flow per share	9.09	8.75	4.13	11.6	11.77
Cash per share	3.5	4.06	12.63	4.91	13.91
Book value per share	22.22	20.23	29.93	37.66	52.01
Tangible book value per share	14.98	12.2	20.46	21.49	-47.44
Share holders equity per share	22.22	20.23	29.93	37.66	52.01
Interest debt per share	27.22	33.91	34.3	38.28	142.54
Market cap	12.08B	15.25B	15.31B	18.69B	11.08B
Enterprise value	15.17B	18.88B	18.28B	22.32B	24.62B
P/E ratio	10.01	17.9	7.71	9.89	5.85
Price to sales ratio	1.69	2.42	2.71	2.19	1.15
POCF ratio	7.76	10.49	18.01	10.64	6.09
PFCF ratio	9.9	14.07	31.5	14.49	8.68
P/B Ratio	4.05	6.08	4.34	4.46	1.97
PTB ratio	4.05	6.08	4.34	4.46	1.97
EV to sales	2.12	3	3.23	2.61	2.54
Enterprise value over EBITDA	9.81	18.71	21.26	10.09	14.06
EV to operating cash flow	9.74	12.98	21.51	12.71	13.53
EV to free cash flow	12.43	17.41	37.62	17.3	19.29
Earnings yield	0.1	0.06	0.13	0.1	0.17
Free cash flow yield	0.1	0.07	0.03	0.07	0.12
Debt to equity	1.18	1.63	1.11	0.99	2.67
Debt to assets	0.38	0.43	0.36	0.35	0.57
Net debt to EBITDA	2	3.59	3.46	1.64	7.73
Current ratio	1.62	1.58	1.91	1.52	1.63
Interest coverage	10.67	7.25	6.09	21.38	3.4
Income quality	1.28	1.69	0.43	0.93	0.96
Dividend Yield	0.02	0.02	0.02	0.02	0.03
Payout ratio	0.23	0.35	0.15	0.16	0.16
Sales general and administrative to revenue	0	0	0	0	0
Research and developement to revenue	0.01	0.01	0.01	0.01	0.01
Intangibles to total assets	0.15	0.15	0.14	0.18	0.43
Capex to operating cash flow	-0.22	-0.25	-0.43	-0.27	-0.3
Capex to revenue	-0.05	-0.06	-0.06	-0.05	-0.06
Capex to depreciation	-0.97	-1.04	-1.02	-1.24	-1.14
Stock based compensation to revenue	0.01	0.01	0	0.01	0.01
Graham number	67.03	55.95	106.53	120	143.01
ROIC	0.17	0.11	0.08	0.19	0.09
Return on tangible assets	0.15	0.11	0.21	0.19	0.13
Graham Net	-29.43	-37.69	-34.85	-43.87	-144.99
Working capital	1.1B	1.01B	1.79B	1.3B	2.54B
Tangible asset value	2.01B	1.51B	2.41B	2.39B	-5.14B
Net current asset value	-3.06B	-3.81B	-3.25B	-3.63B	-13.56B
Invested capital	1.18	1.63	1.11	0.99	2.67
Average receivables	1.27B	1.25B	1.21B	1.45B	1.86B
Average payables	813M	799.5M	788.5M	978.5M	1.34B
Average inventory	973M	1.04B	1.01B	1.25B	2.17B
Days sales outstanding	67.24	68.46	80.16	71.27	77.51
Days payables outstanding	57.68	60.69	66.69	72.31	75.97
Days of inventory on hand	73.66	80.77	81.84	95.01	140.53
Receivables turnover	5.43	5.33	4.55	5.12	4.71
Payables turnover	6.33	6.01	5.47	5.05	4.8
Inventory turnover	4.96	4.52	4.46	3.84	2.6
ROE	0.4	0.34	0.56	0.45	0.34
Capex per share	-2.51	-2.99	-3.09	-4.2	-5.01

Quarterly Fundamentals Overview

Last date of statement is 2023-06-30 for Q2

Metric	2022-06-30	2022-09-30	2022-12-31	2023-03-31	2023-06-30
Revenue per share	22.94	21.22	21.64	26.26	25.67
Net income per share	4	1.76	7.07	0.84	2.02
Operating cash flow per share	4.57	4.31	4.99	-0.88	7
Free cash flow per share	3.42	3.03	3.67	-2.39	5.67
Cash per share	7.29	89.19	13.9	10.74	11.9
Book value per share	45.02	45.65	51.95	52.11	51.64
Tangible book value per share	29.54	30.94	-47.39	-46.9	-45.75
Share holders equity per share	45.02	45.65	51.95	52.11	51.64
Interest debt per share	37.82	117.09	140.19	141.05	137.05
Market cap	12.75B	9.8B	11.09B	11.83B	12.61B
Enterprise value	16.02B	12.67B	24.63B	25.8B	26.06B
P/E ratio	7.34	12.82	3.62	32.5	14.33
Price to sales ratio	5.13	4.26	4.72	4.15	4.51
POCF ratio	25.75	20.98	20.5	-123.22	16.55
PFCF ratio	34.36	29.86	27.87	-45.5	20.44
P/B Ratio	2.61	1.98	1.97	2.09	2.24
PTB ratio	2.61	1.98	1.97	2.09	2.24
EV to sales	6.44	5.5	10.49	9.04	9.32
Enterprise value over EBITDA	28.3	27.6	253.9	86.3	66.14
EV to operating cash flow	32.36	27.12	45.52	-268.78	34.2
EV to free cash flow	43.17	38.62	61.88	-99.24	42.23
Earnings yield	0.03	0.02	0.07	0.01	0.02
Free cash flow yield	0.03	0.03	0.04	-0.02	0.05
Debt to equity	0.83	2.53	2.67	2.67	2.62
Debt to assets	0.32	0.59	0.57	0.58	0.57
Net debt to EBITDA	5.77	6.25	139.54	46.74	34.13
Current ratio	1.72	4.73	1.63	1.67	1.59
Interest coverage	10.06	2.92	0.33	1.38	1.84
Income quality	1.14	2.42	0.7	-1.03	3.45
Dividend Yield	0.01	0.01	0.01	0.01	0.01
Payout ratio	0.17	0.38	0.1	0.84	0.35
Sales general and administrative to revenue	0	0	0	0	0
Research and developement to revenue	0.01	0.01	0.02	0.01	0.01
Intangibles to total assets	0.16	0.09	0.43	0.43	0.43
Capex to operating cash flow	-0.25	-0.3	-0.26	1.71	-0.19
Capex to revenue	-0.05	-0.06	-0.06	-0.06	-0.05
Capex to depreciation	-1.16	-1.32	-0.89	-0.92	-0.8
Stock based compensation to revenue	0.01	0.01	0.01	0	0.01
Graham number	63.69	42.54	90.9	31.34	48.45
ROIC	0.04	0.02	-0.03	0.01	0.02
Return on tangible assets	0.04	0.01	0.05	0.01	0.02
Graham Net	-41.25	-39.67	-144.83	-144.37	-142.66
Working capital	1.86B	10.4B	2.54B	2.6B	2.33B
Tangible asset value	3.2B	3.36B	-5.14B	-5.1B	-4.98B
Net current asset value	-3.03B	-2.85B	-13.56B	-13.51B	-13.31B
Invested capital	0.83	2.53	2.67	2.67	2.62
Average receivables	1.87B	1.72B	1.83B	2.18B	2.14B
Average payables	1.21B	1.19B	1.32B	1.48B	1.34B
Average inventory	1.63B	1.72B	2.27B	2.78B	2.63B
Days sales outstanding	66.14	63.05	78.73	72.97	63.21
Days payables outstanding	63.17	57.85	69.56	58.53	53.04
Days of inventory on hand	86.56	88.36	128.68	111.35	107.28
Receivables turnover	1.36	1.43	1.14	1.23	1.42
Payables turnover	1.42	1.56	1.29	1.54	1.7
Inventory turnover	1.04	1.02	0.7	0.81	0.84
ROE	0.09	0.04	0.14	0.02	0.04
Capex per share	-1.14	-1.28	-1.32	-1.51	-1.33

CE Dividend History

CE Frequently Asked Questions

What is Celanese Corporation stock symbol ?

Celanese Corporation is a US stock , located in Irving of Tx and trading under the symbol CE

Is Celanese Corporation buy or a sell ?

19 stock analysts have 19 predictions with a medium analyst target price of $160.05. The lowest prediction is $111 and the highest is $206

What is CE stock prediction ?

With a median analyst target price of $147, 2 stock analysts have made 2 forecasts in last 90 days. $145 is the lowest and $149 is the greatest projection.

What is Celanese Corporation stock quote today ?

Celanese Corporation stock price is $122.01 today.

Is Celanese Corporation stock public?

Yes, Celanese Corporation is a publicly traded company.

Something similar

Top by Market Cap

Top Correlated ETFs

Top Correlated Stocks

Similar Market Cap

Company Profile

Volume Average 1.26M
Market Capitalization 13.49B
Employee 13.26K
CEO Ms. Lori J. Ryerkerk BS
Headquarters Irving,TX,US
IPO Date 2005-01-21
Website https://www.celanese.com

Celanese Corporation, a technology and specialty materials company, manufactures and sells high performance engineered polymers in the United States and internationally. The company operates through three segments: Engineered Materials, Acetate Tow, and Acetyl Chain. The Engineered Materials segment develops, produces, and supplies specialty polymers for automotive and medical applications, as well as for use in industrial products and consumer electronics. It also offers acesulfame potassium, a sweetener for use in various beverages, confections, and dairy products; and food protection ingredients, such as potassium sorbate and sorbic acid for use in foods, beverages, and personal care products. The Acetate Tow segment provides acetate tows and flakes for use in filter products applications. The Acetyl Chain segment produces and supplies acetyl products, including acetic acid, vinyl acetate monomers, acetic anhydride, and acetate esters that are used as starting materials for colorants, paints, adhesives, coatings, and pharmaceuticals; and organic solvents and intermediates for pharmaceutical, agricultural, and chemical products. It also offers vinyl acetate-based emulsions for use in paints and coatings, adhesives, construction, glass fiber, textiles, and paper applications; and ethylene vinyl acetate resins and compounds, as well as low-density polyethylene for use in flexible packaging films, lamination film products, hot melt adhesives, automotive parts, and carpeting applications. In addition, it manufactures ultra-high molecular weight polyethylene. Celanese Corporation was founded in 1918 and is headquartered in Irving, Texas.